Insider trades

Reardon Andrew

Reardon Andrew made 0 buys and 49 sales on the open market in the last 12 months at Ligand Pharmaceuticals Incorporated. Each trade with the role, price and filing.

DateCompanyTradeSharesPrice
Oct 2, 2026Ligand Pharmaceuticals IncorporatedSale404US$306
Oct 2, 2026Ligand Pharmaceuticals IncorporatedSale833US$303
Oct 2, 2026Ligand Pharmaceuticals IncorporatedSale235US$307
Oct 2, 2026Ligand Pharmaceuticals IncorporatedSale1,976US$304
Oct 2, 2026Ligand Pharmaceuticals IncorporatedSale17US$308
Oct 2, 2026Ligand Pharmaceuticals IncorporatedSale1,535US$305
Sep 3, 2026Ligand Pharmaceuticals IncorporatedSale300US$284
Sep 3, 2026Ligand Pharmaceuticals IncorporatedSale2,115US$286
Sep 3, 2026Ligand Pharmaceuticals IncorporatedSale1,800US$285
Sep 3, 2026Ligand Pharmaceuticals IncorporatedSale385US$288